May 28, 2026
BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual MeetingVIEW RELEASE
May 15, 2026
BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial ResultsVIEW RELEASE
Apr 17, 2026
BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home SettingVIEW RELEASE
Stock Information
BioXcel Therapeutics, Inc.
May 28, 2026 11:31 AM
MARKET/SYMBOL
Nasdaq:
BTAI
PRICE
1.31
CHANGE
0.01 (0%)
